JP2022500054A5 - - Google Patents
Info
- Publication number
- JP2022500054A5 JP2022500054A5 JP2021514594A JP2021514594A JP2022500054A5 JP 2022500054 A5 JP2022500054 A5 JP 2022500054A5 JP 2021514594 A JP2021514594 A JP 2021514594A JP 2021514594 A JP2021514594 A JP 2021514594A JP 2022500054 A5 JP2022500054 A5 JP 2022500054A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleic acid
- sequence
- glycoprotein
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102018215551.8 | 2018-09-12 | ||
| DE102018215551.8A DE102018215551A1 (de) | 2018-09-12 | 2018-09-12 | Verfahren zur Herstellung eines antitumoralen Arenavirus sowie Arenavirusmutanten |
| PCT/EP2019/074307 WO2020053324A1 (en) | 2018-09-12 | 2019-09-12 | Method for producing an antitumoral arenavirus as well as arenavirus mutants |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022500054A JP2022500054A (ja) | 2022-01-04 |
| JP2022500054A5 true JP2022500054A5 (enExample) | 2022-09-15 |
| JP7583448B2 JP7583448B2 (ja) | 2024-11-14 |
Family
ID=68138008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021514594A Active JP7583448B2 (ja) | 2018-09-12 | 2019-09-12 | 抗腫瘍アレナウイルスおよびアレナウイルス変異体を生産するための方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US12129281B2 (enExample) |
| EP (2) | EP4019533A1 (enExample) |
| JP (1) | JP7583448B2 (enExample) |
| KR (1) | KR20210057782A (enExample) |
| CN (2) | CN120158432A (enExample) |
| AU (1) | AU2019340845B2 (enExample) |
| BR (1) | BR112021004451A2 (enExample) |
| CA (1) | CA3111305A1 (enExample) |
| CL (1) | CL2021000592A1 (enExample) |
| DE (1) | DE102018215551A1 (enExample) |
| DK (1) | DK3694868T3 (enExample) |
| ES (1) | ES2908854T3 (enExample) |
| IL (1) | IL281299B2 (enExample) |
| MX (1) | MX2021002937A (enExample) |
| PH (1) | PH12021550424A1 (enExample) |
| SG (1) | SG11202101970UA (enExample) |
| WO (1) | WO2020053324A1 (enExample) |
| ZA (1) | ZA202101833B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024508823A (ja) * | 2021-02-26 | 2024-02-28 | アバロス セラピューティクス ゲーエムベーハー | 治療目的のための新規のウイルス粒子 |
| WO2025046106A1 (en) * | 2023-08-31 | 2025-03-06 | Abalos Therapeutics Gmbh | Virus particles with improved entry into tumor cells |
| CN117867030A (zh) * | 2024-01-15 | 2024-04-12 | 苏州健雄职业技术学院 | 小鼠肺癌细胞系cmt167荧光素酶稳转细胞株的构建与应用 |
| CN121022940B (zh) * | 2025-10-30 | 2026-04-07 | 山东第一医科大学(山东省医学科学院) | 一种抑制塔姆德病毒感染的方法及tcp1抑制剂的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004034461B4 (de) * | 2004-07-16 | 2008-02-07 | Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus | Gentherapie solider Tumore durch retrovirale, mit Arenavirus-Glykoprotein pseudotypisierte Vektoren |
| LT2604695T (lt) | 2007-12-27 | 2022-12-12 | Universität Zürich | Replikacijos defektų turintys arenaviruso vektoriai |
| KR20110074563A (ko) * | 2008-09-24 | 2011-06-30 | 메디뮨 엘엘씨 | 바이러스의 정제 방법 |
| RU2585216C2 (ru) | 2009-03-23 | 2016-05-27 | Институт Пастор | Мутантные полипептиды суаа и производные полипептидов, подходящие для доставки иммуногенных молекул в клетку |
| WO2012093340A2 (en) * | 2011-01-07 | 2012-07-12 | Bioscience Slovakia | Viral diagnostics |
| US20150307559A1 (en) | 2012-12-12 | 2015-10-29 | Children's Hospital Of Eastern Ontario Research Intitute Inc. | Compositions and methods for the treatment of brain cancers |
| DE102015207036A1 (de) * | 2015-04-17 | 2016-10-20 | Karl Sebastian Lang | Arenaviren zur Anwendung bei der Behandlung und/oder Vorbeugung von Tumoren sowie Verfahren zur Herstellung von Arenaviren mit (verbesserten) tumorregressiven Eigenschaften |
| EP3173092B1 (en) | 2015-04-22 | 2019-06-26 | CureVac AG | Rna containing composition for treatment of tumor diseases |
| WO2018083220A2 (en) * | 2016-11-04 | 2018-05-11 | Hookipa Biotech Ag | Replication-deficient arenavirus particles and tri-segmented arenavirus particles as cancer vaccines |
-
2018
- 2018-09-12 DE DE102018215551.8A patent/DE102018215551A1/de not_active Withdrawn
-
2019
- 2019-09-12 WO PCT/EP2019/074307 patent/WO2020053324A1/en not_active Ceased
- 2019-09-12 AU AU2019340845A patent/AU2019340845B2/en active Active
- 2019-09-12 ES ES19782905T patent/ES2908854T3/es active Active
- 2019-09-12 KR KR1020217010631A patent/KR20210057782A/ko active Pending
- 2019-09-12 EP EP21205198.1A patent/EP4019533A1/en active Pending
- 2019-09-12 IL IL281299A patent/IL281299B2/en unknown
- 2019-09-12 JP JP2021514594A patent/JP7583448B2/ja active Active
- 2019-09-12 MX MX2021002937A patent/MX2021002937A/es unknown
- 2019-09-12 US US17/275,967 patent/US12129281B2/en active Active
- 2019-09-12 CN CN202510196120.1A patent/CN120158432A/zh active Pending
- 2019-09-12 SG SG11202101970UA patent/SG11202101970UA/en unknown
- 2019-09-12 CA CA3111305A patent/CA3111305A1/en active Pending
- 2019-09-12 BR BR112021004451-5A patent/BR112021004451A2/pt unknown
- 2019-09-12 CN CN201980074560.2A patent/CN112996802B/zh active Active
- 2019-09-12 DK DK19782905.4T patent/DK3694868T3/da active
- 2019-09-12 EP EP19782905.4A patent/EP3694868B1/en active Active
-
2021
- 2021-03-01 PH PH12021550424A patent/PH12021550424A1/en unknown
- 2021-03-10 CL CL2021000592A patent/CL2021000592A1/es unknown
- 2021-03-18 ZA ZA2021/01833A patent/ZA202101833B/en unknown
-
2024
- 2024-10-25 US US18/927,732 patent/US20250122244A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022163182A5 (enExample) | ||
| JP2007511216A5 (enExample) | ||
| US20250122244A1 (en) | Method for producing an antitumoral arenavirus as well as arenavirus mutants | |
| MX2023008825A (es) | Efecto sinergico de smn1 y mir-23a en el tratamiento de la atrofia muscular espinal. | |
| WO2013118544A1 (ja) | タンパク質の分泌生産法 | |
| Wallat et al. | High-resolution structure of the N-terminal endonuclease domain of the Lassa virus L polymerase in complex with magnesium ions | |
| JP2019047790A (ja) | Ｌ−アミノ酸を生産する微生物、及びそれを利用してｌ−アミノ酸を生産する方法 | |
| De Vlugt et al. | Priming and realignment by the influenza a virus RdRp is dependent on the length of the host primers and the extent of base pairing to viral RNA | |
| JP2020526202A5 (enExample) | ||
| CN108866099A (zh) | 特异性抑制肺腺癌细胞miRNA-21-5p表达的重组慢病毒载体及其构建方法 | |
| US20080299617A1 (en) | Methods and host cells for recombinant protein expression | |
| RU2021104395A (ru) | Способ продуцирования аренавируса, а также мутантов аренавируса с противоопухолевыми свойствами | |
| US20230045095A1 (en) | Compositions, Methods and Systems for the Delivery of Gene Editing Material to Cells | |
| CN111467493A (zh) | 人rev3l蛋白切割抑制剂及其应用 | |
| JP2024508823A5 (enExample) | ||
| JP2017046594A (ja) | γ−Ｇｌｕ−Ａｂｕの製造法およびγ−Ｇｌｕ−Ａｂｕを含有する酵母エキスの製造法 | |
| NZ774584B2 (en) | Method for producing an antitumoral arenavirus as well as arenavirus mutants | |
| CN107502610A (zh) | 一种靶向STAT3信号通路miRNA及其制备方法和应用 | |
| JP6874996B2 (ja) | 人工ｒｎａ制限酵素 | |
| CN109182279B (zh) | 一种选择性杀灭肿瘤干细胞的新型溶瘤病毒及其构建方法 | |
| CN104946602A (zh) | 具有肿瘤组织靶向性和抑癌基因修复性的重组溶瘤腺病毒Ad5-P16及其应用 | |
| HK40054624B (zh) | 用於制备抗肿瘤沙粒病毒的方法以及沙粒病毒突变体 | |
| CN110538192A (zh) | 一种HDAC4信号通路miRNA抑制剂及其过表达方法和应用 | |
| DOWHAM et al. | STRUCTURE OF PHOSPHATIDYLSERINE DECARBOXYLASE | |
| HK40054624A (en) | Method for producing an antitumoral arenavirus as well as arenavirus mutants |